Participants 34 101 6
patients receiving androgen deprivation therapy for prostate cancer
Participants 185 209 3
advanced prostate cancer
Participants 356 410 4
patients with prostate cancer during androgen ablation
Participants 753 848 6
Forty-eight osteoporotic patients with prostate cancer, treated with 3-month depot triptorelina
